Quipt Home Medical Corp.

Equities

QIPT

CA74880P1045

Healthcare Facilities & Services

Delayed Toronto S.E. Other stock markets 10:31:53 16/07/2024 pm IST			5-day change	1st Jan Change
4.44 ^CAD	+5.21%		+10.72%	-34.22%

01/07	Quipt Home Medical Corp.(NasdaqCM:QIPT) added to Russell Small Cap Comp Value Index	CI
01/07	Quipt Home Medical Corp.(NasdaqCM:QIPT) added to Russell 3000 Value Index	CI

Patient Home Monitoring Corp. Reports Revenue Results for the Year Ended September 30, 2016; Provides Revenue Guidance for the First Quarter of Fiscal 2017

January 24, 2017 at 07:49 pm IST

Patient Home Monitoring Corp. reported revenue results for the year ended September 30, 2016. Revenues for the year ended September 30, 2016 were approximately $139,244,000.

Revenues for the first quarter of 2017 are expected to be approximately $30 million -$31 million which is slightly lower than the fourth quarter.

Latest news about Quipt Home Medical Corp.

Quipt Home Medical Corp.(NasdaqCM:QIPT) added to Russell Small Cap Comp Value Index	01/07	CI
Quipt Home Medical Corp.(NasdaqCM:QIPT) added to Russell 3000 Value Index	01/07	CI
Quipt Home Medical Corp.(NasdaqCM:QIPT) added to Russell 2500 Value Index	01/07	CI
Quipt Home Medical Corp.(NasdaqCM:QIPT) added to Russell 2000 Value Index	01/07	CI
Quipt Home Medical Corp.(NasdaqCM:QIPT) dropped from Russell 2000 Growth-Defensive Index	01/07	CI
Quipt Home Medical Corp.(NasdaqCM:QIPT) dropped from Russell 2000 Defensive Index	01/07	CI
Quipt Home Medical Corp.(NasdaqCM:QIPT) added to Russell Microcap Value Index	01/07	CI
Quipt Home Medical Corp.(NasdaqCM:QIPT) added to Russell 3000E Value Index	01/07	CI
Benchmark Trims Price Target on Quipt Home Medical to $9 From $10, Maintains Buy Rating	20/05	MT
Canaccord Genuity Adjusts Price Target on Quipt Home Medical to $8 From $9, Maintains Buy Rating	17/05	MT
Raymond James Downgrades Quipt Home Medical to Underperform	17/05	MT
Transcript : Quipt Home Medical Corp., Q2 2024 Earnings Call, May 16, 2024	16/05
Quipt Home Medical Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	16/05	CI
Quipt Home Medical Corp. Brief: Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue	16/05	MT
Quipt Home Medical Corp. Brief: Revenue for Q2 2024 was US$64.0 million compared to $58.1 million for Q2 2023, representing a 10% increase	16/05	MT
Quipt Home Medical Corp. announces an Equity Buyback for 3,626,845 shares, representing 8.52% for CAD 5 million.	02/05	CI
Quipt Home Medical Announces 10% Stock Buyback	02/05	MT
Quipt Home Medical Corp. authorizes a Buyback Plan.	02/05	CI
Quipt Home Medical Maintained at Buy at Stifel GMP After Fiscal Q1 Results; Price Target Cut to C$10.50	16/02	MT
Transcript : Quipt Home Medical Corp., Q1 2024 Earnings Call, Feb 15, 2024	15/02
Quipt Home Medical Corp. Brief: Revenue for Q1 2024 was US$65.4 million compared to $40.8 million for Q1 2023; Net income (loss) for Q1 2024 was $(0.6) million, or ($0.01) per diluted share	15/02	MT
Quipt Home Medical Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	15/02	CI
North American Morning Briefing :Stock Futures -2-	14/02	DJ
Quipt Home Medical Corp. Brief: Shelf Prospectus and Registration Statement, when made final and effective, will enable Co to offer Up to C$300,000,000 of common shares, preferred shares, debt securities, warrants	28/12	MT
Quipt Home Medical Corp. Brief: Announced Filing of Preliminary Base Shelf Prospectus to Replace Recently Expired Base Shelf Prospectus	28/12	MT

Chart Quipt Home Medical Corp.

Duration

Period

More charts

Company Profile

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.

Sector

Healthcare Facilities & Services

Calendar

19/08/2024 - Q3 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Quipt Home Medical Corp.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

4.22 CAD

Average target price

12 CAD

Spread / Average Target

+184.36%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
QUIPT HOME MEDICAL CORP.	-34.22%	131M
HCA HEALTHCARE, INC.	+17.52%	83.02B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.85%	26.5B
FRESENIUS SE & CO. KGAA	+5.31%	17.72B
LABCORP HOLDINGS INC.	-5.85%	17.49B
QUEST DIAGNOSTICS INCORPORATED	+6.89%	16.06B
NATERA, INC.	+79.65%	13.83B
TENET HEALTHCARE CORPORATION	+76.63%	12.84B
PURE HEALTH HOLDING	-26.49%	12.73B
REDE D'OR SÃO LUIZ S.A.	+2.68%	12.19B

Other Healthcare Facilities & Services